This text will be discovered within the MyWallSt App, alongside an audio companion. Sign up today for a free account and get entry to dozens of expertly written articles and analyst opinion items each month.
It’s been simply over 1,600 days since we added Teladoc (NYSE: TDOC) to the MyWallSt shortlist and after a rollercoaster of a time, our complete returns so far are principally break even. What occurred to our one-time high-flier?
It was solely two months in the past that Teladoc’s administration got here out with some very optimistic up to date steerage — presumably hoping to stem the tide of this relentless selloff in high-growth names. Nonetheless, final week, the grim brutality of actuality hit traders like a truck. This isn’t, sadly, a kind of circumstances the place we are able to say the market has overreacted. Final week’s report was, in a phrase, horrific.
What did Teladoc report in its most up-to-date earnings name?
Income missed. That alone was going to be sufficient to panic traders. Despite the fact that it was a small miss, the market is taking no prisoners proper now relating to non-profitable names.
Right here’s what my colleague Emmet had to say when he noticed the outcomes:
“Taking a look at Teladoc’s report, roughly all of the numbers have been consistent with analyst expectations, which is sweet… or no less than, not dangerous.
- Income elevated 25% to $565 million in comparison with Q1 2021.
- Entry charges income grew 29% to $491 million
- Go to charge income grew 12% to $67.9 million.
- U.S. Revenues grew 24% to $491.2 million
- Income per person elevated 20.5% to $2.52
- Worldwide revenues grew 27% to $74.2 million.
- Members grew 5% to 54.4 million
…all of that claims that the enterprise is doing what we hoped and anticipated.”
In some ways he’s proper. The core telehealth enterprise does appear to be performing fairly effectively, if not fairly in addition to one would have hoped. Nonetheless, the dangerous information hides proper beneath these headline figures…
